Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 1
2014 1
2016 1
2019 1
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients.
Panagiota V, Kerschbaum JF, Penack O, Stein CM, Arends CM, Koenecke C, Strzelecka PM, Kloos A, Wiegand L, Lasch A, Altwasser R, Halik A, Gabdoulline R, Thomson J, Weibl K, Franke GN, Berger C, Hasenkamp J, Ayuk F, Na IK, Beutel G, Keller U, Bullinger L, Wulf GG, Kröger N, Vucinic V, Heuser M, Damm F. Panagiota V, et al. Hemasphere. 2023 Oct 3;7(10):e957. doi: 10.1097/HS9.0000000000000957. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37799345 Free PMC article.
Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia.
Panagiota V, Dobbelstein C, Werwitzke S, Ganser A, Cooper N, Sachs UJ, Tiede A. Panagiota V, et al. Viruses. 2022 Aug 1;14(8):1702. doi: 10.3390/v14081702. Viruses. 2022. PMID: 36016324 Free PMC article.

This single-center consecutive cohort study included all patients diagnosed based on (1) vaccination 4 to 21 days before symptom onset, (2) signs or symptoms of venous or arterial thrombosis, (3) thrombocytopenia < 150/nL, (4) positive anti-platelet factor 4 (PF4) antib

…
This single-center consecutive cohort study included all patients diagnosed based on (1) vaccination 4 to 21 days before symptom onset, (2) …
Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers.
Economopoulou P, Kotsantis I, Psyrri A. Economopoulou P, et al. Curr Treat Options Oncol. 2016 Aug;17(8):40. doi: 10.1007/s11864-016-0419-z. Curr Treat Options Oncol. 2016. PMID: 27315066 Review.
The discovery and antibody targeting of immune regulatory molecules such as programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) pathways have led to clinically meaningful anti-cancer results. Rapid advances are being made in a variety of tu …
The discovery and antibody targeting of immune regulatory molecules such as programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyt …
Adrenal gland injury after blunt abdominal trauma: Two case series and review of the literature.
Papadopoulos KS, Strigklis K, Kordeni K, Xaplanteri P, Zacharis G. Papadopoulos KS, et al. Int J Surg Case Rep. 2020;67:34-38. doi: 10.1016/j.ijscr.2020.01.021. Epub 2020 Jan 27. Int J Surg Case Rep. 2020. PMID: 32004901 Free PMC article.
Both where complaining of intense pain in the right flank. Neither were under anti-coagulant or anti-platelet therapy. In both patients thoracoabdominal CE-CT revealed the injury. ...
Both where complaining of intense pain in the right flank. Neither were under anti-coagulant or anti-platelet therapy. In both …
Serum-derived MHC class II molecules: potent regulators of the cellular and humoral immune response.
Marios-Frankiskos S, Panagiota M, Katerina B, Athanassakis I. Marios-Frankiskos S, et al. Immunobiology. 2010 Mar;215(3):194-205. doi: 10.1016/j.imbio.2009.04.005. Epub 2009 May 20. Immunobiology. 2010. PMID: 19457570
Inhibition of the CD4 co-receptor using specific neutralizing antibodies destroyed the sIA(d)-mediated proliferative activity, while sIA(d) successfully antagonized surface IA(d) antigens for binding to anti-IA(d) antibody. Serum-IA(d) stimulated BALB/c versus C3H/HeN but …
Inhibition of the CD4 co-receptor using specific neutralizing antibodies destroyed the sIA(d)-mediated proliferative activity, while sIA(d) …
Expression of junctional adhesion molecule-C on the surface of platelets supports adhesion, but not differentiation, of human CD34 cells in vitro.
Stellos K, Panagiota V, Gnerlich S, Borst O, Bigalke B, Gawaz M. Stellos K, et al. Cell Physiol Biochem. 2012;29(1-2):153-62. doi: 10.1159/000337596. Epub 2012 Mar 1. Cell Physiol Biochem. 2012. PMID: 22415084 Free article.
The role of JAM-C and its counter receptor Mac-1 in adhesion of human CD34(+) cells over immobilized platelets was investigated by using a neutralizing soluble protein (sJAM-C-Fc) and a monoclonal antibody against JAM-C or integrin Mac-1 (CD11b/CD18). Treatment with soluble JAM-C …
The role of JAM-C and its counter receptor Mac-1 in adhesion of human CD34(+) cells over immobilized platelets was investigated by using a n …